Search Results

You are looking at 1 - 4 of 4 items for :

  • Biology and Life Sciences x
  • All content x
Clear All

, Bross PF , Farrell AT , Pazdur R : Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy . The Oncologist 8 , 508 – 513 ( 2003 ) 2

Open access
Acta Biologica Hungarica
Authors: Eszter László, P. Kiss, Gabriella Horváth, P. Szakály, Andrea Tamás, and Dóra Reglődi

myeloma kidney injury. Blood 107 , 661–668. Batuman V. Potential protective action of pituitary adenylate cyclase activating polypeptide (PACAP38) on in vitro and in vivo models of

Restricted access

genotoxicity on human multiple myeloma cells (ARH-77) . Pharma. Biol. 51 , 766 – 770 . 16. İşeri, Ö. D., Körpe , D. A. , Yurtcu , E. , Sahin , F. I. , Haberal , M. ( 2015 ) Seed priming to increase

Restricted access

, Z. 2009. Different levels of humoral immunoreactivity to different wheat cultivars gliadin are present in patients with celiac disease and in patients with multiple myeloma. BMC Immunology 10 :1–7. Juranic Z

Restricted access